Reference health
Simultaneous determination of multicomponent of acetylkitasamycin and kitasamycin by LC–MS/MS in swine plasma and its application in a pharmacokinetic study
23/23 checkable references clean · checked 2026-07-22
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
7 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 23 checked references that resolve
resolves10.1111/j.1365-2885.2008.00982.x
Pharmacokinetics of erythromycin after the administration of intravenous and various oral dosage forms to dogs
resolves10.1016/j.tvjl.2009.09.019
Pharmacokinetics of erythromycin after intravenous, intramuscular and oral administration to cats
resolves10.1016/S0731-7085(99)00143-0
Microbiological bioassay of erythromycin thiocyanate: optimisation and validation
resolves10.2165/00003088-199834040-00003
Pharmacodynamics and Pharmacokinetics of Spiramycin and Their Clinical Significance
resolves10.1002/j.1552-4604.1993.tb05613.x
Single‐ and Multiple‐dose Pharmacokinetics of Clarithromycin, a New Macrolide Antimicrobial
resolves10.1128/AAC.32.4.561
Pharmacokinetic advantages of erythromycin estolate over ethylsuccinate as determined by high-pressure liquid chromatography
resolves10.1039/a909876c
High-performance liquid chromatographic assay of erythromycin from biological matrix using electrochemical or ultraviolet detection
resolves10.1111/j.1365-2885.1994.tb00516.x
Comparison of oral erythromycin formulations in the horse using pharmacokinetic profiles
resolves10.2165/00003088-199528020-00005
The Importance of Pharmacokinetic/Pharmacodynamic Surrogate Markers to Outcome
resolves10.1016/S0021-9673(97)01279-X
Determination of macrolides in biological matrices by high-performance liquid chromatography with electrochemical detection
resolves10.1016/S0731-7085(97)00095-2
Sensitive determination of erythromycin in human plasma by LC-MS/MS
resolves10.1111/jvp.12404
Pharmacokinetic and pharmacodynamic integration and modeling of acetylkitasamycin in swine for<i>Clostridium perfringens</i>
resolves10.7164/antibiotics.21.532
STRUCTURE-BIOLOGICAL ACTIVITIES RELATIONSHIPS AMONG LEUCOMYCINS AND THEIR DERIVATIVES
resolves10.7164/antibiotics.28.401
Chemical and biological studies on 16-membered macrolide antibiotics.
resolves10.1128/AAC.44.5.1209-1213.2000
Comparison of High-Performance Liquid Chromatographic and Microbiological Methods for Determination of Voriconazole Levels in Plasma
resolves10.1128/AAC.38.9.1922
Pharmacokinetics of spiramycin in the rhesus monkey: transplacental passage and distribution in tissue in the fetus
resolves10.1128/AAC.22.6.976
Radioimmunoassay for metabolites of 9,3"-diacetylmidecamycin, a macrolide antibiotic
resolves10.1016/S0021-9673(01)82035-5
High-performance liquid chromatographic analysis of josamycin in serum and urine
resolves10.1021/ac60366a033
Fluorometric determination of erythromycin and erythromycin propionate in whole blood or plasma and correlation of results with microbiological assay
resolves10.1128/AAC.15.5.738
Biosynthesis of Kitasamycin(Leucomycin) by Leucine Analog-Resistant Mutants of
<i>Streptomyces kitasatoensis</i>
resolves10.1016/j.jchromb.2004.11.055
Simultaneous determination of erythromycin propionate and base in human plasma by high-performance liquid chromatography–electrospray mass spectrometry
resolves10.1016/S1570-0232(03)00205-8
Determination of three major components of bitespiramycin and their major active metabolites in rat plasma by liquid chromatography-ion trap mass spectrometry
The 7 references without a DOI — listed, not checked
no DOI — not checkedPharmacopoeia of the People's Republic of China, Part II
no DOI — not checkedEMA(2005).Veterinary medicinal products for veterinary use acetylisovalerytylosin (extend to poultry) (4) EMA/CVMP/77339/2005.
no DOI — not checkedEMEA(1997).Committee for veterinary medicinal tylosin (3) EMEA/MRL/205/97‐FINAL.
no DOI — not checkedLeucomycin, a new antibiotic
no DOI — not checkedClinical pharmacokinetics and pharmacodynamics concepts and applications
no DOI — not checkedUS Department of Health and Human Services US Food and Drug Administration(2013).Draft Guidance for Industry: Bioanalytical Method Validation (Revised). Retrieved fromwww.fda.gov/downloads/Drugs/Guidance%20Compliance%20Regulatory%20Information/Guidances/UCM368107.pdf
no DOI — not checkedRelative bioavailability of acetylkitasamycin granules in healthy volunteers
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-22 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1002/bmc.4268"><img src="https://citestamp.com/citestamped/10.1002/bmc.4268/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1002/bmc.4268)